Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study

Author

P. Bidulka

M. Iwagami

K. Mansfield

F. Kalogirou

A. Wong

I. Douglas

L. Smeeth

C. Summers

L. Tomlinson

Year of Publication

2020

DOI

10.12688/wellcomeopenres.15873.1

• DOI
• Google Scholar
• BibTeX
• EndNote X3 XML
• EndNote 7 XML
• Endnote tagged
• Marc
• RIS